Search

everythinglearnresearchcommunity

for

Search:↓

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

New compounds with carborane showed anti-androgen effects similar to flutamide.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Longer CAG repeats in gene linked to more severe hair loss in females.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Certain gene variations might be linked to severe acne in women but not in men.

Women with hair loss have more androgen receptors in certain hair follicles.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

No significant link between CAG repeat numbers and female pattern hair loss in Han Chinese population.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Finasteride may improve prostate cancer treatment outcomes.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Lowering testosterone speeds up wound healing in male mice.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.